In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
about
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironmentConstruction of recombinant eukaryotic expression plasmid containing murine CD40 ligand gene and its expression in H22 cells.Cationic liposome-mediated transfection of CD40 ligand gene inhibits hepatic tumor growth of hepatocellular carcinoma in mice.AdCD40L--crossing the valley of death?Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors.
P2860
In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
In vitro activation of cancer ...... lly modified to express CD154.
@en
In vitro activation of cancer ...... lly modified to express CD154.
@nl
type
label
In vitro activation of cancer ...... lly modified to express CD154.
@en
In vitro activation of cancer ...... lly modified to express CD154.
@nl
prefLabel
In vitro activation of cancer ...... lly modified to express CD154.
@en
In vitro activation of cancer ...... lly modified to express CD154.
@nl
P2860
P356
P1433
P1476
In vitro activation of cancer ...... lly modified to express CD154.
@en
P2093
Andreas Böhle
Thomas H Tötterman
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700507
P577
2002-10-01T00:00:00Z
P5875
P6179
1019663681